Alexion Pharmaceuticals
Theresa Katz currently serves as Senior Director and Head of Strategy and Business Planning in Research at Alexion Pharmaceuticals, Inc., a position held since November 2017. Prior roles at Alexion include Director, Chief of Staff for Research, Bioinformatics and Diagnostics, as well as Director of Commercial Excellence in Value, Insights, and Strategy Operations. Previously, Theresa held multiple Vice President positions at Interpublic Group (IPG) from January 2013 to November 2017, overseeing account management and professional education. Earlier career experiences include Vice President at Hospicom and Director of Educational Services at Advanstar Communications, along with an Account Director role at Thomson Gardiner-Caldwell. Education was completed at Binghamton University.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.